
TriVascular, Inc
Has pioneered numerous design and manufacturing technologies in pursuit of our commitment to providing optimal solutions for endovascular aortic repair (EVAR).
Employees
Enterprise value
$211m
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | €0.0 | round |
investor investor investor investor | €0.0 | round | |
investor investor investor investor | €0.0 | round | |
investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor investor investor investor investor | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
$211m Valuation: $211m | Acquisition | ||
Total Funding | 000k |

MPM BioImpact(exited)

NEA(exited)

Kaiser Permanente Ventures(exited)

Redmile Group(exited)

Delphi Ventures(exited)

Pinnacle Ventures(exited)

Kearny Venture Partners(exited)

CRG LP(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.